| INTRODUCTION
Radical prostatectomy (RP) is the primary curative treatment option for patients with localized prostate cancer (PCa). Nevertheless, recurrence after RP occurs in approximately one third of the patients. 1, 2 Predicting disease recurrence remains a major challenge due to the complex nature of PCa and while postoperative factors such as Gleason score (GS) and pathological stage are useful as prognostic factors, 3 there are no molecular biomarkers that can reliably predict biochemical recurrence (BCR). Identifying factors that contribute to BCR could help clarify our understanding of prostate cancer biology and enhance our ability to identify patents that may benefit from post-surgical adjuvant therapy.
Homeobox genes are transcriptional regulators that play critical roles in controlling morphogenesis, differentiation and regional development along the anteroposterior axis during embryogenesis. 4, 5 The human genome contains 39 homeobox genes, which are categorized into four families (HOXA, HOXB, HOXC, and HOXD). 6 In the developing embryo, the homeobox proteins HOXA10, HOXA13
and HOXD13 modulate morphogenesis and normal development of the prostate gland. 7 However, aberrant expression of homeobox genes is often observed in cancers and have been implicated with increased tumor growth, proliferation, angiogenesis and cell cycle. 8 HOXA9 and HOXB13 are the two HOX genes most commonly associated with solid tumors while overexpression of HOXC is observed in human prostate cancer.
9
HOXA10 has been shown to play both tumor promoting and tumor suppressing roles in various solid cancer models. [10] [11] [12] [13] Furthermore, a positive correlation was observed between HOXA10 expression and patient prognosis in gastric cancer, whereas, a negative correlation was reported in ovarian adenocarcinoma thus indicating that HOXA10 acts in a context-dependent manner. 14, 15 To further elucidate the clinical significance of HOXA10 in human cancer, we focused on examining the evaluating HOXA10 expression in human prostate adenocarcinoma and its associations with clinicopathological features. We further examined its temporal expression in a well-established mouse model of Pten-deficient PCa. 16 2 | MATERIAL AND METHODS
| Human mRNA data
HOXA10 gene expression analysis were performed using publicly available datasets in the Oncomine cancer microarray database. Table 1 .
| Immunohistochemical (IHC) analysis
Tissue microarrays, consisting of prostate tumor and normal adjacent tissue, were constructed from formalin-fixed paraffin embedded tissue blocks. Selected donor blocks, originally assessed for pathological examination after surgery, were pulled and representative areas of tumor and normal adjacent tissue were marked and cored (2-5 1.5 mm cores) using a custom manual coring instrument and embedded into recipient blocks. Serial sections were cut and placed on positively charged slides. A slide was stained with hematoxylin and eosin for confirmation by a trained urologist.
For IHC studies, adjacent serial sections were subjected to An index score (IS) was determined by the product of intensity × distribution. The final index score represents the average value from two independent blinded scorers. Gapdh as an internal control.
IHC of HOXA10 was performed in formalin-fixed paraffin embedded tissue sections of mouse prostates collected at the indicated time and stained as previously described.
| Statistical analysis
Data were reported as mean values ± standard error unless noted. A two-tailed Student's t-test used for paired analysis and one-way ANOVA on ranks for multiple comparisons. Correlations between HOXA10 expression and clinicopathological features were performed using Pearson's correlation. We used receiver operating characteristics (ROC) analysis to identify the optimal cutoff value of the HOXA10 IS.
Associations between high HOXA10 (IS ≥150) or low HOXA10
(IS <150) and clinicopathological features were calculated using A P < 0.05 was considered statistically significant.
3 | RESULTS
| Meta-analysis of HOXA10 gene expression in human tissues
We first performed a meta-analysis of HOXA10 gene expression in human normal and cancer tissues using publicly available datasets from the Oncomine microarray database. 17 Overall, HOXA10 mRNA levels were higher in normal reproductive organs including prostate, uterus and vagina ( Figure 1A) . In normal prostate, HOXA10 levels had fold increases of 8.040, P < 0.001 and 14.730, P < 0.001 in normal versus normal analysis, Roth Normal and Roth Normal 2, respectively. In the Brittner multi-cancer data set, colorectal, prostate and esophageal cancer had the greatest levels of HOXA10 overexpression, exhibiting fold changes of 3.400, P < 0.001; 3.133, P < 0.001; and 2.464, P < 0.015, respectively ( Figure 1B) . Notably, six of eight prostate cancer datasets showed decreased levels of HOXA10 in tumor tissues versus normal prostate tissues ( Figure 1C ). [18] [19] [20] [21] [22] [23] [24] [25] These findings suggest that HOXA10 is critical for normal prostate maintenance and support the notion that dysregulated expression may be associated with PCa.
| Characterization of HOXA10 expression in human prostate cancer
To determine the clinical significance of HOXA10 in human prostate cancer, we performed immunohistochemical analyses on prostate tissue microarrays consisting of normal adjacent and cancer tissue cores from 112 patients that underwent radical prostatectomy (Table 1) Figure 3A-B) . However, the HOXA10 expression was inversely associated with histological grade and pathological stage (Table 2 and Figures 3B and 3C) . A single case of metastatic PCa was available for evaluation and scored but was not included in the analysis since it was a single case. However expression in the metastatic lesion was higher than the primary, HOXA IS 180 versus 70, respectively.
| Association between HOXA10 expression and clinical features
A HOXA10 IS of 150 was determined to be the optimal cutoff value for the HOXA10 expression analysis (Figure 4 ). Statistically significant associations between high and low HOXA10 index scores were observed for GS and tumor differentiation ( Table 3 ).
The significance of HOXA10 expression and the probability of biochemical recurrence after RP were further explored by KaplanMeier analysis. Patients with low HOXA10 expression (HOXA10 IS ≤150) experienced shorter times to biochemical recurrence compared to patients with high HOXA10 expression (P = 0.045; Figure 5 ).
On univariate analysis, low HOXA10 IS revealed a marginal statistically relevant association for biochemical recurrence (OR 3.54, P = 0.049), but was not an independent predictor (OR 1.52, P = 0.52, Table 4 ).
| Reduced HOXA10 is observed in a mouse Ptennull prostate cancer model
To provided further insights into the potential biological significance of HOXA10 and prostate cancer, we examined HOXA10 in a transgenic mouse model of prostate cancer that closely mimics human prostate cancer. 16 HOXA10 mRNA levels were lower in prostate tumors from Pten-deficient prostates compared to those of wildtype mice (P < 0.001, Figure 6A ). 15 and promoted oral squamous cell carcinoma proliferation, migration and invasion. 33 The biological and clinical significance of HOXA10 in PCa has not been determined. Here, we have shown that HOXA10 expression was inversely associated with tumor differentiation, a feature that is similar to both gastric 14 and ovarian 12 cancers. We found no significant differences between cancer and normal adjacent tissue in matching cases. We also noted that HOXA10 expression had a Gaussian distribution in histologically normal prostate glands whereas a bimodal distribution was observed in PCa ( Figure 3A) . Moreover, HOXA10
expression was higher in Gleason pattern three compared to normal tissues, but the exhibited grade-dependent decrease. It is possible that normal tissues may not be truly normal 22 In summary, we have used human and mouse prostate cancer tissues to characterize HOXA10. From a clinical perspective, HOXA10
expression was inversely related to tumor differentiation and high HOXA10 expression was associated with longer times to BCR.
Together our data provides evidence to link HOXA10 and PCa, however, more work is need to define the precise biological functions of HOXA10 in PCa.
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